1,161 research outputs found

    Chemical Modification of Polaronic States in Anatase TiO2(101)

    Get PDF
    Two polymorphs of TiO2, anatase and rutile, are employed in photocatalytic applications. It is broadly accepted that anatase is the more catalytically active and subsequently finds wider commercial use. In this work, we focus on the Ti3+ polaronic states of anatase TiO2(101), which lie at ∼1.0 eV binding energy and are known to increase catalytic performance. Using UV-photoemission and two-photon photoemission spectroscopies, we demonstrate the capability to tune the excited state resonance of polarons by controlling the chemical environment. Anatase TiO2(101) contains subsurface polarons which undergo sub-band-gap photoexcitation to states ∼2.0 eV above the Fermi level. Formic acid adsorption dramatically influences the polaronic states, increasing the binding energy by ∼0.3 eV. Moreover, the photoexcitation oscillator strength changes significantly, resonating with states ∼3.0 eV above the Fermi level. We show that this behavior is likely due to the surface migration of subsurface oxygen vacancies

    Decreasing Atmospheric CO2 During the Late Miocene Cooling

    Get PDF
    A pronounced late Miocene cooling (LMC) from ~7 to 5.7 Ma has been documented in extratropical and tropical sea surface temperature records, but to date, available proxy evidence has not revealed a significant pCO2 decline over this event. Here, we provide a new, high‐resolution pCO2 proxy record over the LMC based on alkenone carbon isotopic fractionation (εp) measured in sediments from the South Atlantic at Ocean Drilling Program (ODP) Site 1088. We apply a recent proxy calibration derived from a compilation of laboratory cultures, which more accurately reflects the proxy sensitivity to pCO2 changes during late Quaternary glacial‐interglacial cycles, together with new micropaleontological proxies to reconstruct past variations in algal growth rate, an important secondary influence on the εp. Our resulting pCO2 record suggests an approximately twofold to threefold decline over the LMC and confirms a strong coupling between climate and pCO2 through the late Miocene. Within this long‐term trend are pCO2 variations on sub‐myr timescales that may reflect 400‐kyr long‐eccentricity cycles, in which pCO2 minima coincide with several orbital‐scale maxima in published high‐resolution benthic δ18O records. These may correspond to ephemeral glaciations, potentially in the Northern Hemisphere. Our temperature and planktonic δ18O records from Site 1088 are consistent with substantial equatorward movement of Southern Ocean frontal systems during the LMC. This suggests that potential feedbacks between cooling, ocean circulation and deep ocean CO2 storage may warrant further investigation during the LMC

    Photoexcitation of bulk polarons in rutile TiO₂

    Get PDF
    The excitation of surface-localized polaronic states has recently been discussed as an additional photocatalytic channel to band gap excitation for rutile Ti O 2 . A contribution from photoexcitation of bulk polarons could, in principle, provide a greater contribution because of their higher number and their protection from oxidation. However, determining such a contribution to the photoyield is challenging and has not been achieved thus far. Here we use two photon photoemission spectroscopy measurements to separate bulk and surface polaron photoexcitation. We find that bulk polarons are less bound by 0.2 eV compared with polarons at the surface, consistent with our results of hybrid density functional theory calculations. Because the excited state is also shifted to higher energy, bulk polarons have the same photoexcitation resonance energy as at the surface (3.6 eV) with a threshold at 3.1 eV. This is degenerate with the band gap, suggesting that bulk polarons could also provide an additional contribution to the photoyield

    Normal values and test–retest variability of stimulated-echo diffusion tensor imaging and fat fraction measurements in the muscle

    Get PDF
    OBJECTIVES: To assess the test–retest variability of both diffusion parameters and fat fraction (FF) estimates in normal muscle, and to assess differences in normal values between muscles in the thigh. METHODS: 29 healthy volunteers (mean age 37 years, range 20–60 years, 17/29 males) completed the study. Magnetic resonance images of the mid-thigh were acquired using a stimulated echo acquisition mode-echoplanar imaging (STEAM-EPI) imaging sequence, to assess diffusion, and 2-point Dixon imaging, to assess FF. Imaging was repeated in 19 participants after a 30 min interval in order to assess test–retest variability of the measurements. RESULTS: Intraclass correlation coefficients (ICCs) for test–retest variability were 0.99 [95% confidence interval, (CI): 0.98, 1] for FF, 0.94 (95% CI: 0.84, 0.97) for mean diffusivity and 0.89 (95% CI: 0.74, 0.96) for fractional anisotropy (FA). FF was higher in the hamstrings than the quadriceps by a mean difference of 1.81% (95% CI:1.63, 2.00)%, p < 0.001. Mean diffusivity was significantly lower in the hamstrings than the quadriceps (0.26 (0.13, 0.39) x10- 3 mm2s−1, p < 0.001) whereas fractional anisotropy was significantly higher in the hamstrings relative to the quadriceps with a mean difference of 0.063 (0.05, 0.07), p < 0.001. CONCLUSIONS: This study has shown excellent test-retest, variability in MR-based FF and diffusion measurements and demonstrated significant differences in these measures between hamstrings and quadriceps in the healthy thigh. ADVANCES IN KNOWLEDGE: Test–retest variability is excellent for STEAM-EPI diffusion and 2-point Dixon-based FF measurements in the healthy muscle. Inter- and intraobserver variability were excellent for region of interest placement for STEAM-EPI diffusion and 2-point Dixon-based FF measurements in the healthy muscle. There are significant differences in FF and diffusion measurements between the hamstrings and quadriceps in the normal muscle

    Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.

    Get PDF
    The gold standard for a definitive diagnosis of Parkinson disease (PD) is the pathologic finding of aggregated α-synuclein into Lewy bodies and for Alzheimer disease (AD) aggregated amyloid into plaques and hyperphosphorylated tau into tangles. Implicit in this clinicopathologic-based nosology is the assumption that pathologic protein aggregation at autopsy reflects pathogenesis at disease onset. While these aggregates may in exceptional cases be on a causal pathway in humans (e.g., aggregated α-synuclein in SNCA gene multiplication or aggregated β-amyloid in APP mutations), their near universality at postmortem in sporadic PD and AD suggests they may alternatively represent common outcomes from upstream mechanisms or compensatory responses to cellular stress in order to delay cell death. These 3 conceptual frameworks of protein aggregation (pathogenic, epiphenomenon, protective) are difficult to resolve because of the inability to probe brain tissue in real time. Whereas animal models, in which neither PD nor AD occur in natural states, consistently support a pathogenic role of protein aggregation, indirect evidence from human studies does not. We hypothesize that (1) current biomarkers of protein aggregates may be relevant to common pathology but not to subgroup pathogenesis and (2) disease-modifying treatments targeting oligomers or fibrils might be futile or deleterious because these proteins are epiphenomena or protective in the human brain under molecular stress. Future precision medicine efforts for molecular targeting of neurodegenerative diseases may require analyses not anchored on current clinicopathologic criteria but instead on biological signals generated from large deeply phenotyped aging populations or from smaller but well-defined genetic-molecular cohorts

    The frequency and validity of self-reported diagnosis of Parkinson's Disease in the UK elderly: MRC CFAS cohort

    Get PDF
    BACKGROUND: Estimates of the incidence and prevalence of chronic diseases can be made using established cohort studies but these estimates may have lower reliability if based purely on self-reported diagnosis. METHODS: The MRC Cognitive Function & Ageing Study (MRC CFAS) has collected longitudinal data from a population-based random sample of 13004 individuals over the age of 65 years from 5 centres within the UK. Participants were asked at baseline and after a two-year follow-up whether they had received a diagnosis of Parkinson's disease. Our aim was to make estimates of the incidence and prevalence of PD using self-reporting, and then investigate the validity of self-reported diagnosis using other data sources where available, namely death certification and neuropathological examination. RESULTS: The self-reported prevalence of Parkinson's disease (PD) amongst these individuals increases with age from 0.7% (95%CI 0.5–0.9) for 65–75, 1.4% (95%CI 1.0–1.7) for 75–85, and 1.6% (95%CI 1.0–2.3) for 85+ age groups respectively. The overall incidence of self reported PD in this cohort was 200/100,000 per year (95%CI 144–278). Only 40% of the deceased individuals reporting prevalent PD and 35% of those reporting incident PD had diagnoses of PD recorded on their death certificates. Neuropathological examination of individuals reporting PD also showed typical PD changes in only 40%, with the remainder showing basal ganglia pathologies causing parkinsonism rather than true PD pathology. CONCLUSION: Self-reporting of PD status may be used as a screening tool to identify patients for epidemiological study, but inevitably identifies a heterogeneous group of movement disorders patients. Within this group, age, male sex, a family history of PD and reduced cigarette smoking appear to act as independent risk factors for self-reported PD
    corecore